|
US3898330A
(en)
|
1973-08-01 |
1975-08-05 |
Squibb & Sons Inc |
Corticosteroid phosphate salts/neomycin sulfate ophthalmic
|
|
US4525359A
(en)
*
|
1982-12-10 |
1985-06-25 |
Greenway Frank L Iii |
Treatment for selective weight control
|
|
NZ212204A
(en)
|
1984-06-04 |
1988-07-28 |
Merck & Co Inc |
Growth-promoting compositions containing hydroxylic compounds
|
|
GB8426672D0
(en)
|
1984-10-22 |
1984-11-28 |
Erba Farmitalia |
Pharmaceutical compositions
|
|
JPH0696521B2
(ja)
|
1986-01-31 |
1994-11-30 |
千寿製薬株式会社 |
眼局所投与用眼圧降下剤
|
|
FR2602423B1
(fr)
|
1986-08-08 |
1989-05-05 |
Ethypharm Sa |
Procede de preparation d'un medicament a base de fenofibrate, medicament obtenu par ce procede
|
|
US5270305A
(en)
|
1989-09-08 |
1993-12-14 |
Glaxo Group Limited |
Medicaments
|
|
CA2030174C
(en)
|
1990-01-10 |
1996-12-24 |
Anthony H. Cincotta |
Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hypoglycemia in vertebrates
|
|
US5126147A
(en)
|
1990-02-08 |
1992-06-30 |
Biosearch, Inc. |
Sustained release dosage form
|
|
US5919827A
(en)
|
1990-07-11 |
1999-07-06 |
Sepracor Inc. |
Method for treating asthma using optically pure R(-) salmeterol
|
|
SE9302777D0
(sv)
|
1993-08-27 |
1993-08-27 |
Astra Ab |
Process for conditioning substances
|
|
SK282826B6
(sk)
|
1991-12-18 |
2002-12-03 |
Aktiebolaget Astra |
Farmaceutická kompozícia na podávanie inhaláciou s obsahom formoterolu a budesonidu a jej použitie
|
|
US5314916A
(en)
|
1993-04-19 |
1994-05-24 |
Alcon Laboratories, Inc. |
B2 adrenegic agonists and use thereof in the treatment of glaucoma
|
|
US6316443B1
(en)
|
1994-08-04 |
2001-11-13 |
Merck & Co., Inc. |
Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a β-adrenergic antagonist
|
|
GB9512854D0
(en)
|
1995-06-23 |
1995-08-23 |
Wellcome Found |
Novel formulation
|
|
US5855913A
(en)
|
1997-01-16 |
1999-01-05 |
Massachusetts Instite Of Technology |
Particles incorporating surfactants for pulmonary drug delivery
|
|
AU4582797A
(en)
|
1996-09-13 |
1998-04-02 |
Regents Of The University Of California, The |
Methods for treatment of retinal diseases
|
|
ATE413415T1
(de)
|
1996-09-19 |
2008-11-15 |
Univ Michigan |
Polymere enthaltend polysaccharide wie alginate oder modifizierte alginate
|
|
SE9700135D0
(sv)
|
1997-01-20 |
1997-01-20 |
Astra Ab |
New formulation
|
|
TW469832U
(en)
|
1997-03-14 |
2001-12-21 |
Astra Ab |
Inhalation device
|
|
CN1269722A
(zh)
|
1997-03-18 |
2000-10-11 |
Basf公司 |
调节对皮质类固醇反应的方法及组合物
|
|
US6656508B2
(en)
|
1997-04-17 |
2003-12-02 |
Amgen Inc. |
Sustained-release alginate gels
|
|
WO1998048810A1
(en)
|
1997-04-30 |
1998-11-05 |
Bridge Pharma, Inc. |
Composition and methods using an eutomer
|
|
US20010044584A1
(en)
|
1997-08-28 |
2001-11-22 |
Kensey Kenneth R. |
In vivo delivery methods and compositions
|
|
SE9703407D0
(sv)
|
1997-09-19 |
1997-09-19 |
Astra Ab |
New use
|
|
JPH11106334A
(ja)
*
|
1997-09-30 |
1999-04-20 |
Saitama Daiichi Seiyaku Kk |
尿失禁治療剤
|
|
US20030095925A1
(en)
|
1997-10-01 |
2003-05-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
|
|
US20040152664A1
(en)
|
1998-09-02 |
2004-08-05 |
Allergan, Inc. |
Prednisolone compositions
|
|
US6384259B1
(en)
|
1998-11-16 |
2002-05-07 |
Medimmune Oncology, Inc. |
Stable amorphous amifostine compositions and dosage form
|
|
WO2001019373A2
(en)
|
1999-09-17 |
2001-03-22 |
Basf Aktiengesellschaft |
Methods and compositions for modulating responsiveness to corticosteroids
|
|
GB9924992D0
(en)
|
1999-10-21 |
1999-12-22 |
Glaxo Group Ltd |
Pharmaceutical aerosol formulations
|
|
US6569903B2
(en)
|
1999-12-07 |
2003-05-27 |
Rohto Pharmaceutical Co., Ltd. |
Ophthalmic compositions
|
|
US20040208910A1
(en)
|
2000-04-26 |
2004-10-21 |
Control Delivery Systems, Inc. |
Sustained release device and method for ocular delivery of adrenergic agents
|
|
GB0012260D0
(en)
|
2000-05-19 |
2000-07-12 |
Astrazeneca Ab |
Novel composition
|
|
AUPQ797700A0
(en)
|
2000-06-06 |
2000-06-29 |
Austin Research Institute, The |
Vaccine
|
|
US6936426B2
(en)
|
2000-10-06 |
2005-08-30 |
Harbor-Ucla Research And Education Institute |
Detection of antibody mediated inflammatory auto-immune disorders
|
|
FI20002216A0
(fi)
|
2000-10-06 |
2000-10-06 |
Orion Yhtymae Oyj |
Yhdistelmäpartikkelit astman hoitoon
|
|
FI20002215A0
(fi)
|
2000-10-06 |
2000-10-06 |
Orion Yhtymae Oyj |
Yhdistelmäpartikkelit
|
|
JP2004513340A
(ja)
|
2000-11-03 |
2004-04-30 |
ヒストオテック エーピーエス |
組織ブロックを切片化するための装置および方法
|
|
ES2260321T3
(es)
|
2000-12-07 |
2006-11-01 |
Universiteit Utrecht Holding B.V. |
Composicion para el tratamiento de transtornos inflamatorios.
|
|
US20030022856A1
(en)
|
2001-01-30 |
2003-01-30 |
The Regents Of The University Of Michigan |
Method for sustained release local delivery of drugs for ablation of unwanted tissue
|
|
UA77656C2
(en)
|
2001-04-07 |
2007-01-15 |
Glaxo Group Ltd |
S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
|
|
US20030055026A1
(en)
|
2001-04-17 |
2003-03-20 |
Dey L.P. |
Formoterol/steroid bronchodilating compositions and methods of use thereof
|
|
MY137522A
(en)
|
2001-04-30 |
2009-02-27 |
Glaxo Group Ltd |
Novel anti-inflammatory androstane derivatives.
|
|
GB0124523D0
(en)
|
2001-10-12 |
2001-12-05 |
Glaxo Group Ltd |
Pharmaceutical combination
|
|
JP2005508220A
(ja)
|
2001-10-24 |
2005-03-31 |
パーリ・ゲーエムベーハー |
薬用組成物調製用具
|
|
US6625078B2
(en)
|
2002-02-11 |
2003-09-23 |
United Memories, Inc. |
Look-ahead refresh for an integrated circuit memory
|
|
US8541399B2
(en)
|
2002-02-19 |
2013-09-24 |
Resolution Chemicals Limited |
Solvent-based sterilisation of pharmaceuticals
|
|
US20050009798A1
(en)
|
2002-02-20 |
2005-01-13 |
Sepracor Inc. |
Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonists
|
|
US6643212B1
(en)
|
2002-04-18 |
2003-11-04 |
United Memories, Inc. |
Simultaneous function dynamic random access memory device technique
|
|
AU2003263717A1
(en)
|
2002-09-25 |
2004-04-19 |
Astrazeneca Ab |
A COMBINATION OF A LONG-ACTING Beta2-AGONIST AND A GLUCOCORTICOSTEROID IN THE TREATMENT OF FIBROTIC DISEASES
|
|
CA2500065A1
(en)
|
2002-09-30 |
2004-04-15 |
Acusphere, Inc. |
Sustained release porous microparticles for inhalation
|
|
US20040208833A1
(en)
|
2003-02-04 |
2004-10-21 |
Elan Pharma International Ltd. |
Novel fluticasone formulations
|
|
EP1613266A4
(en)
|
2003-04-15 |
2009-05-06 |
Theraquest Biosciences Llc |
METHOD FOR TREATING PAIN AND COMPOSITIONS FOR USE THEREOF
|
|
US9808471B2
(en)
|
2003-04-16 |
2017-11-07 |
Mylan Specialty Lp |
Nasal pharmaceutical formulations and methods of using the same
|
|
WO2004103057A2
(en)
*
|
2003-05-15 |
2004-12-02 |
The University Of Georgia Research Foundation, Inc. |
Compositions and methods for inducing adipose tissue cell death
|
|
EP1635844A1
(en)
|
2003-05-22 |
2006-03-22 |
ALTANA Pharma AG |
Salmeterol and ciclesonide combination
|
|
SE0302029D0
(sv)
|
2003-07-07 |
2003-07-07 |
Astrazeneca Ab |
Novel process
|
|
TWI359675B
(en)
|
2003-07-10 |
2012-03-11 |
Dey L P |
Bronchodilating β-agonist compositions
|
|
GB0316290D0
(en)
|
2003-07-11 |
2003-08-13 |
Glaxo Group Ltd |
Novel compounds
|
|
GB2403655A
(en)
|
2003-07-11 |
2005-01-12 |
Cipla Ltd |
Combined pharmaceutical product comprising a beta-2 adrenoreceptor agonist & an antihistamine for treatment of respiratory diseases such as asthma
|
|
JP2007508240A
(ja)
|
2003-07-22 |
2007-04-05 |
バクスター・インターナショナル・インコーポレイテッド |
低分子量有機分子の小球状粒子ならびにその調製方法および使用方法
|
|
BRPI0414907A
(pt)
|
2003-09-30 |
2006-11-07 |
Acusphere Inc |
formulações farmacêuticas com liberação sustentada injetáveis, orais ou tópicas
|
|
US20050075900A1
(en)
|
2003-10-02 |
2005-04-07 |
Arguimbau Vincent C. |
Method and apparatus for bulk food marking and tracking with supplier rating system
|
|
DE10347994A1
(de)
|
2003-10-15 |
2005-06-16 |
Pari GmbH Spezialisten für effektive Inhalation |
Wässrige Aerosol-Zubereitung
|
|
CN105820160B
(zh)
|
2003-11-05 |
2019-02-12 |
萨可德生物科学公司 |
细胞粘着调节剂
|
|
AU2004292416B2
(en)
*
|
2003-11-20 |
2010-01-28 |
Alteragon Pty Ltd |
Method of decreasing fat deposits and body weight in mammals and birds
|
|
KR100573828B1
(ko)
|
2003-12-29 |
2006-04-26 |
주식회사 하이닉스반도체 |
셀데이터의 손실을 방지하기 위한 반도체 메모리 소자
|
|
US20080270175A1
(en)
|
2003-12-31 |
2008-10-30 |
Klinger Advanced Aesthetics, Inc. |
Systems and methods using a dynamic expert system to provide patients with aesthetic improvement procedures
|
|
US20050212152A1
(en)
|
2004-03-23 |
2005-09-29 |
Reens Daniel J |
System and method for humidifying homes and commercial sites
|
|
US7754230B2
(en)
|
2004-05-19 |
2010-07-13 |
The Regents Of The University Of California |
Methods and related compositions for reduction of fat
|
|
US7317023B2
(en)
|
2004-07-21 |
2008-01-08 |
Theravance, Inc. |
Diaryl ether β2 adrenergic receptor agonists
|
|
EP1819318A1
(en)
|
2004-11-24 |
2007-08-22 |
Seo Hong Yoo |
Dried forms of aqueous solubilized bile acid dosage formulation
|
|
EP1867334A4
(en)
|
2005-02-18 |
2009-07-15 |
Santen Pharmaceutical Co Ltd |
METHOD FOR RELIEVING OR AVOIDING A SECONDARY EFFECT OF A STEROID COMPOUND
|
|
WO2006108176A2
(en)
|
2005-04-08 |
2006-10-12 |
The Regents Of The University Of California |
Wound healing composition
|
|
US7931909B2
(en)
|
2005-05-10 |
2011-04-26 |
Allergan, Inc. |
Ocular therapy using alpha-2 adrenergic receptor compounds having enhanced anterior clearance rates
|
|
CN1706501A
(zh)
|
2005-05-27 |
2005-12-14 |
沈阳药科大学 |
亲脂性药物环糊精包合物的制备方法
|
|
CN101252842A
(zh)
*
|
2005-07-14 |
2008-08-27 |
利波西拉公司 |
用于局部脂肪组织治疗的持续释放的增强性脂肪分解性制剂
|
|
ES2384641T3
(es)
|
2005-07-14 |
2012-07-10 |
Lithera, Inc. |
Formulación lipolítica que potencia la liberación mantenida para el tratamiento localizado del tejido adiposo
|
|
US8158152B2
(en)
|
2005-11-18 |
2012-04-17 |
Scidose Llc |
Lyophilization process and products obtained thereby
|
|
FR2893845B1
(fr)
|
2005-11-30 |
2010-10-29 |
Galderma Sa |
Composition sous forme de spray comprenant un corticoide et une phase huileuse
|
|
EP1973523A2
(en)
|
2005-12-15 |
2008-10-01 |
Acusphere, Inc. |
Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration
|
|
US20070178051A1
(en)
|
2006-01-27 |
2007-08-02 |
Elan Pharma International, Ltd. |
Sterilized nanoparticulate glucocorticosteroid formulations
|
|
JP2009532489A
(ja)
|
2006-04-03 |
2009-09-10 |
テバ ファーマシューティカル インダストリーズ リミティド |
薬剤微粒子
|
|
DE102007026979A1
(de)
|
2006-10-06 |
2008-04-10 |
Friedrich Siller |
Inhalationsvorrichtung
|
|
CN101626759B
(zh)
*
|
2006-10-17 |
2014-08-06 |
利特拉公司 |
用于治疗甲状腺眼病的组合物和制剂
|
|
PL2077830T3
(pl)
*
|
2006-10-17 |
2013-04-30 |
Lithera Inc |
Sposoby, kompozycje i formulacje do leczenia orbitopatii tarczycowej
|
|
US20100063006A1
(en)
|
2006-11-22 |
2010-03-11 |
American Network Of Lipolysis, Llc |
Compositions and methods to reduce fat and retract skin
|
|
WO2008122118A1
(en)
|
2007-04-04 |
2008-10-16 |
Theratechnologies Inc. |
Pharmaceutical formulations of ghrh molecules
|
|
ES2592289T3
(es)
*
|
2007-04-24 |
2016-11-29 |
Acacia Pharma Limited |
Combinación de fármacos y su uso en el tratamiento de la pérdida de músculo
|
|
US20090208492A1
(en)
|
2007-06-14 |
2009-08-20 |
Elan Pharmaceuticals, Inc. |
Lyophilized Immunoglobulin Formulations and Methods of Preparation
|
|
SI2170348T1
(sl)
|
2007-06-22 |
2016-12-30 |
Dompe Farmaceutici S.P.A. |
Šumeče tablete za inhalacijsko uporabo
|
|
US20090131386A1
(en)
|
2007-11-13 |
2009-05-21 |
Meritage Pharma, Inc. |
Compositions for the treatment of inflammation of the gastrointestinal tract
|
|
WO2009073051A1
(en)
|
2007-12-03 |
2009-06-11 |
Bridge Pharma, Inc. |
Use of rr/sr-ractopamine
|
|
US9132084B2
(en)
|
2009-05-27 |
2015-09-15 |
Neothetics, Inc. |
Methods for administration and formulations for the treatment of regional adipose tissue
|
|
BR112012017556A2
(pt)
|
2010-01-15 |
2016-08-16 |
Lithera Inc |
formulações de torta liofilizada
|